Beyond Cannabis: Plants and the Endocannabinoid System

Total Page:16

File Type:pdf, Size:1020Kb

Beyond Cannabis: Plants and the Endocannabinoid System TIPS 1329 No. of Pages 12 Review Beyond Cannabis: Plants and the Endocannabinoid System Ethan B. Russo1,* Plants have been the predominant source of medicines throughout the vast Trends majority of human history, and remain so today outside of industrialized socie- The endocannabinoid system (ECS) is ties. One of the most versatile in terms of its phytochemistry is cannabis, whose a homeostatic regulator of neurotrans- investigation has led directly to the discovery of a unique and widespread mitter activity and almost every other homeostatic physiological regulator, the endocannabinoid system. While it physiological system in the body. had been the conventional wisdom until recently that only cannabis harbored Its name derives from cannabis, the active agents affecting the endocannabinoid system, in recent decades the plant that produces cannabinoids (tet- fi rahydrocannabinol, cannabidiol, caryo- search has widened and identi ed numerous additional plants whose compo- phyllene, and others), and whose nents stimulate, antagonize, or modulate different aspects of this system. These investigation elucidated the myriad include common foodstuffs, herbs, spices, and more exotic ingredients: kava, functions of the ECS. chocolate, black pepper, and many others that are examined in this review. In the past two decades, additional research has discovered that many Overview of the Endocannabinoid System other plant foods and herbs modulate Cannabis (Cannabis sativa) has been an important tool in the herbalist's arsenal and the medical the ECS directly and indirectly. Advan- pharmacopoeia for millennia, but it has only been in the past 25 years that science has provided cing this knowledge may have impor- tant implications for human health and a better understanding of its myriad benefits. This began with the discovery of cannabinoid nutrition. receptors (see Glossary) [CB1,CB2, and the ionotropic cannabinoid receptor, transient receptor potential vanilloid 1 (TRPV1)], followed by endogenous cannabinoids [or endo- cannabinoids, anandamide (AEA), and 2-arachidonoylglycerol (2-AG)] and their regulatory metabolic and catabolic enzymes [fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL), and others], the triad now known collectively as the endocannabinoid system (ECS) [1,2]. The ECS performs major regulatory homeostatic functions in the brain, skin, digestive tract, liver, cardiovascular system, genitourinary function, and even bone [1,3]. Various lifestyle factors including diet and aerobic activity affect the overall ECS function or ‘endocan- nabinoid tone’, a function of the density of cannabinoid receptors, their functional status (upregulated or downregulated) and relative abundance or dearth of endocannabinoids (see [4] for an excellent review). Some have been sufficiently bold as to suggest that a clinical endo- cannabinoid deficiency underlies many human maladies producing pain and psychiatric dis- turbances [4,5]. Recently, numerous herbal agents and food plants beyond cannabis have been examined for their possible modulatory effects on the ECS. Perhaps it is appropriate to alter slightly the common adage to reflect, ‘You are what you ingest’, as perhaps there are many more lessons to be learned in the foraged forests and fields that may help to nurture human health. Plants Affecting CB1, the Psychoactive Cannabinoid Receptor CB1, the neuromodulatory cannabinoid receptor, was discovered in 1988 as a result of decades of research on tetrahydrocannabinol (THC), the primary psychoactive component of cannabis [6], and has proven to have a major homeostatic influence in the central nervous system (CNS), wherein it is the most abundant G-protein-coupled receptor (GPCR) [7], far exceeding those for 1PHYTECS, 20402 81st Avenue SW, the neurotransmitters that it modulates. A similar integral role is played in various other Vashon, WA 98070, USA physiological systems throughout the body. The ECS functions have been characterized as, ‘ ’ relax, eat, sleep, forget and protect [8], but the list of systems it modulates increases each year *Correspondence: with additional research discoveries. [email protected] (E.B. Russo). Trends in Pharmacological Sciences, Month Year, Vol. xx, No. yy http://dx.doi.org/10.1016/j.tips.2016.04.005 1 © 2016 Elsevier Ltd. All rights reserved. TIPS 1329 No. of Pages 12 It has been a long-held belief that natural substances that affected CB1 were limited to THC and Glossary 8 a few other phytocannabinoids (cannabinol, D -THC, tetrahydrocannabivarin), but that situation Adaptogen: a botanical agent that has changed of late, as other plants that modulate the receptor deserve examination. In this era promotes homeostasis, alleviates of genetically modified organisms (GMOs), experimentation has yielded transgenic Pichia fatigue, anxiety and distress, and improves everyday functions without spp. yeasts that express tetrahydrocannabinolic acid (THCA) synthase [9,10], the biosynthetic producing prominent associated enzyme that catalyzes formation of THCA, the agent in cannabis that becomes THC upon adverse events. heating and decarboxylation, and this effort may extend in the future to attempts to synthesize Allosteric modulator: an agent that novel cannabinoids. binds to a separate site on a receptor than the main (orthosteric) site that alters its binding properties. That notwithstanding, efforts have commenced to identify similar psychoactive molecules in The effect may increase (positive other plants. One such effort pertained to Salvia divinorum, a psychoactive divinatory plant of allosteric modulator, PAM) or Mexico that is smoked or ingested as a dissociative hallucinogen. This agent had previously decrease (negative allosteric TM modulator, NAM) binding properties. tested negatively in a NovaScreen for neurotransmitter receptors [11]. Interestingly, although Anandamide salvinorin A, the primary active molecule in the plant was negative for CB1 activity, extracts of the (arachidonylethanolamide, AEA): whole leaves were positive [12] (Figure 1). Shortly after this report, salvinorin A was identified as a is an endogenous ligand for the CB1 fi receptor, from Ananda, the Sanskrit speci c k-opioid agonist [13]. Subsequent work demonstrated that this substance had a low ‘ ’ fi word for bliss . CB1 af nity and no effects on endocannabinoid degradation [14], and the next year salvinorin A 2-Arachidonoylglycerol (2-AG): an was shown to interact with CB1/k-opioid receptor dimers [15], possibly indicating that the two endocannabinoid that is a full agonist systems might produce converging effects on the same pathway, and indicating that a complex at CB1 and CB2 receptors. relationship of Salvia to the ECS deserves to be more fully elucidated. Cannabimimetic: a substance that mimics the effects of cannabis or a cannabinoid. Another common foodstuff, the carrot, Daucus carota, contains falcarinol (carotatoxin), a natural Cannabinoids: are of three types: phytocannabinoids are plant-based pesticide and fungicide, in concentrations of 2 mg/kg [16], which covalently binds CB1 chemicals in cannabis and rarely in (K = 594 nM) (Figure 1), acting as an inverse agonist, blocking AEA in keratinocytes, and i other plants, endocannabinoids are producing contact dermatitis in the presence of histamine. The particular relevance of these endogenous chemicals in chordates findings remains to be determined and would include consideration of whether carrots pose a that bind cannabinoid receptors, while synthetic cannabinoids were particular allergy risk or, whether, despite their high glycemic index, the CB1 antagonism may developed to interact with these suggest their use as an appetite suppressant if carotatoxin is even absorbed via the gastroin- systems. testinal tract. Cannabinoid receptors: G-protein- coupled receptors where one or Kava kava, Piper methysticum,the‘mystic pepper’, is a convivial beverage of the South another of THC, anandamide, and 2- fi AG bind. The best known are CB1, Paci c Islands derived from the plant's roots [17,18], whose active ingredients are lipid- the psychoactive, neuromodulatory, soluble kavalactones. Dried rhizomes may be chewed or, alternatively, are extracted in water, and analgesic receptor, and CB2,an sometimes with the addition of ethanol or acetone. Clinical studies have usually been anti-inflammatory immunomodulatory performed with a standardized extract, WS1490. The kavalactones have been most closely receptor, but also TRPV1, the ionotropic cannabinoid receptor for associated with GABAB receptor activity affecting anxiety and muscle tone, but one major capsaicin that regulates temperature such component, yangonin, has recently demonstrated significant CB1-binding activity and pain responses. Cannabinoid tetrad: a set of four (Ki = 729 nM, with 65.4% displacement of CP55940 at 10 mM, and 98.4% at 25 mM) [19] (Figure 1). Whether yangonin is a CB agonist or antagonist is under current investigation. It signs in animal experiments that a 1 substance stimulates CB : fi 1 demonstrated no signi cant binding at CB2, and other kavalactones were inactive at both hypomotility, catalepsy, analgesia, receptors. Given that yangonin has few off-target liabilities (COX-2 inhibition, 34% displace- and hypothermia. ment only at a lofty concentration, 387 mM [20]), this component deserves additional study, Desensitization: when the continued presence of an agonist at especially since the fact that traditional preparation of kava may yield 250–1250 mg of the receptor reduces its effects and yangonin per serving,
Recommended publications
  • Chronic Pelvic Pain M
    Guidelines on Chronic Pelvic Pain M. Fall (chair), A.P. Baranowski, S. Elneil, D. Engeler, J. Hughes, E.J. Messelink, F. Oberpenning, A.C. de C. Williams © European Association of Urology 2008 TABLE OF CONTENTS PAGE 1. INTRODUCTION 5 1.1 The guideline 5 1.1.1 Publication history 5 1.2 Level of evidence and grade recommendations 5 1.3 References 6 1.4 Definition of pain (World Health Organization [WHO]) 6 1.4.1 Innervation of the urogenital system 7 1.4.2 References 8 1.5 Pain evaluation and measurement 8 1.5.1 Pain evaluation 8 1.5.2 Pain measurement 8 1.5.3 References 9 2. CHRONIC PELVIC PAIN 9 2.1 Background 9 2.1.1 Introduction to urogenital pain syndromes 9 2.2 Definitions of chronic pelvic pain and terminology (Table 4) 11 2.3 Classification of chronic pelvic pain syndromes 12 Table 3: EAU classification of chronic urogenital pain syndromes (page 10) Table 4: Definitions of chronic pain terminology (page 11) Table 5: ESSIC classification of types of bladder pain syndrome according to the results of cystoscopy with hydrodistension and of biopsies (page 13) 2.4 References 13 2.5 An algorithm for chronic pelvic pain diagnosis and treatment 13 2.5.1 How to use the algorithm 13 2.6 Prostate pain syndrome (PPS) 15 2.6.1 Introduction 16 2.6.2 Definition 16 2.6.3 Pathogenesis 16 2.6.4 Diagnosis 17 2.6.5 Treatment 17 2.6.5.1 Alpha-blockers 17 2.6.5.2 Antibiotic therapy 17 2.6.5.3 Non-steroidal anti-inflammatory drugs (NSAIDs) 17 2.6.5.4 Corticosteroids 17 2.6.5.5 Opioids 17 2.6.5.6 5-alpha-reductase inhibitors 18 2.6.5.7 Allopurinol 18 2.6.5.8
    [Show full text]
  • TRP Mediation
    molecules Review Remedia Sternutatoria over the Centuries: TRP Mediation Lujain Aloum 1 , Eman Alefishat 1,2,3 , Janah Shaya 4 and Georg A. Petroianu 1,* 1 Department of Pharmacology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] (L.A.); Eman.alefi[email protected] (E.A.) 2 Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates 3 Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman 11941, Jordan 4 Pre-Medicine Bridge Program, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] * Correspondence: [email protected]; Tel.: +971-50-413-4525 Abstract: Sneezing (sternutatio) is a poorly understood polysynaptic physiologic reflex phenomenon. Sneezing has exerted a strange fascination on humans throughout history, and induced sneezing was widely used by physicians for therapeutic purposes, on the assumption that sneezing eliminates noxious factors from the body, mainly from the head. The present contribution examines the various mixtures used for inducing sneezes (remedia sternutatoria) over the centuries. The majority of the constituents of the sneeze-inducing remedies are modulators of transient receptor potential (TRP) channels. The TRP channel superfamily consists of large heterogeneous groups of channels that play numerous physiological roles such as thermosensation, chemosensation, osmosensation and mechanosensation. Sneezing is associated with the activation of the wasabi receptor, (TRPA1), typical ligand is allyl isothiocyanate and the hot chili pepper receptor, (TRPV1), typical agonist is capsaicin, in the vagal sensory nerve terminals, activated by noxious stimulants.
    [Show full text]
  • To Download the PDF File
    Biological Activities of Selected Dietary Apiaceae, Lamiaceae, and Fabaceae By Huang Huang A Thesis Submitted to the Faculty of Graduate Studies and Research of Carleton University, in partial fulfillment of the requirements for the degree of a Master of Science in Biology Department of Biology Carleton University Ottawa, ON, Canada 2010 © Copyright 2010, Huang Huang i Library and Archives Blbliotheque et 1*1 Canada Archives Canada Published Heritage Direction du Branch Patrimoine de l'6dition 395 Wellington Street 395, rue Wellington OttawaONK1A0N4 OttawaONK1A0N4 Canada Canada Your file Votre reference ISBN: 978-0-494-71582-6 Our file Notre reference ISBN: 978-0-494-71582-6 NOTICE: AVIS: The author has granted a non­ L'auteur a accorde une licence non exclusive exclusive license allowing Library and permettant a la Blbliotheque et Archives Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par telecommunication ou par Nntemet, preter, telecommunication or on the Internet, distribuer et vendre des theses partout dans le loan, distribute and sell theses monde, a des fins commerciales ou autres, sur worldwide, for commercial or non­ support microforme, papier, electronique et/ou commercial purposes, in microform, autres formats. paper, electronic and/or any other formats. The author retains copyright L'auteur conserve la propriete du droit d'auteur ownership and moral rights in this et des droits moraux qui protege cette these. Ni thesis. Neither the thesis nor la these ni des extraits substantiels de celle-ci substantial extracts from it may be ne doivent etre imprimes ou autrement printed or otherwise reproduced reproduits sans son autorisation.
    [Show full text]
  • The Role of Cannabinoids in Dermatology
    COMMENTARY The role of cannabinoids in dermatology Jessica S. Mounessa, BS,a,b Julia A. Siegel, BA,c Cory A. Dunnick, MD,a,b and Robert P. Dellavalle, MD, PhD, MSPHa,b Aurora and Denver, Colorado, and Worcester, Massachusetts Key words: cannabinoid; cannabis; dermatitis; endocannabinoid; inflammatory skin disease; keratinocyte carcinoma; melanoma; palmitoylethanolamide; pruritus; skin cancer; tetrahydrocannabinol. wenty-eight states currently allow for Abbreviations used: comprehensive public medical cannabis programs, and this number continues to CB1: cannabinoid 1 T1 CB2: cannabinoid 2 grow. Approximately 1 in 10 adult cannabis users in 2 PEA: palmitoylethanolamide the United States use it for medical purposes. THC: tetrahydrocannabinol Numerous studies have investigated its uses for chronic pain, spasticity, anorexia, and nausea. In recent years, researchers have also investigated its work independently of descending inhibitory use for the treatment of dermatologic conditions pathways.5 including pruritus, inflammatory skin disease, and Cannabinoids may also have anti-inflammatory skin cancer. properties useful for the treatment of both allergic Perhaps the most promising role for cannabinoids contact dermatitis and atopic dermatitis. Petrosino is in the treatment of itch. In a study of patients with et al6 reported that mice released PEA in response to uremic pruritus on maintenance hemodialysis, 2,4-dinitrofluorobenzeneeinduced allergic contact topical application of a cream with structured dermatitis as an endogenous protective agent. PEA physiologic lipids (derma membrane structure) and may work to reduce later stages of allergic contact endogenous cannabinoids applied twice daily for dermatitis, including mast-cell infiltration, angiogen- 3 weeks completely eliminated pruritus in 8 of 21 esis, and itching.7-9 Tetra-hydrocannabinol (THC) patients (38%).
    [Show full text]
  • A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies
    Comparative Medicine Vol 69, No 6 Copyright 2019 December 2019 by the American Association for Laboratory Animal Science Pages 520–534 Overview A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies George J DeMarco1* and Elizabeth A Nunamaker2 One of the most significant challenges facing investigators, laboratory animal veterinarians, and IACUCs, is how to bal- ance appropriate analgesic use, animal welfare, and analgesic impact on experimental results. This is particularly true for in vivo studies on immune system function and inflammatory disease. Often times the effects of analgesic drugs on a particu- lar immune function or model are incomplete or don’t exist. Further complicating the picture is evidence of the very tight integration and bidirectional functionality between the immune system and branches of the nervous system involved in nociception and pain. These relationships have advanced the concept of understanding pain as a protective neuroimmune function and recognizing pathologic pain as a neuroimmune disease. This review strives to summarize extant literature on the effects of pain and analgesia on immune system function and inflammation in the context of preclinical in vivo studies. The authors hope this work will help to guide selection of analgesics for preclinical studies of inflammatory disease and immune system function. Abbreviations and acronyms: CB,Endocannabinoid receptor; CD,Crohn disease; CFA, Complete Freund adjuvant; CGRP,Calcitonin gene-related
    [Show full text]
  • Review Article Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development
    Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2015, Article ID 238482, 26 pages http://dx.doi.org/10.1155/2015/238482 Review Article Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development Charu Sharma,1 Bassem Sadek,2 Sameer N. Goyal,3 Satyesh Sinha,4 Mohammad Amjad Kamal,5,6 and Shreesh Ojha2 1 Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, Abu Dhabi, UAE 2Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, Abu Dhabi, UAE 3DepartmentofPharmacology,R.C.PatelInstituteofPharmaceuticalEducation&Research,Shirpur,Mahrastra425405,India 4Department of Internal Medicine, College of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA 5King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia 6Enzymoics, 7 Peterlee Place, Hebersham, NSW 2770, Australia Correspondence should be addressed to Shreesh Ojha; [email protected] Received 24 April 2015; Accepted 24 August 2015 Academic Editor: Ki-Wan Oh Copyright © 2015 Charu Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The cannabinoid molecules are derived from Cannabis sativa plant which acts on the cannabinoid receptors types 1 and 2 (CB1 and CB2) which have been explored as potential therapeutic targets for drug discovery and development. Currently, there are 9 numerous cannabinoid based synthetic drugs used in clinical practice like the popular ones such as nabilone, dronabinol, and Δ - tetrahydrocannabinol mediates its action through CB1/CB2 receptors.
    [Show full text]
  • Purinergic P2 Receptors As Targets for Novel Analgesics
    Pharmacology & Therapeutics 110 (2006) 433 – 454 www.elsevier.com/locate/pharmthera Purinergic P2 receptors as targets for novel analgesics Geoffrey Burnstock * Autonomic Neuroscience Centre, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK Abstract Following hints in the early literature about adenosine 5V-triphosphate (ATP) injections producing pain, an ion-channel nucleotide receptor was cloned in 1995, P2X3 subtype, which was shown to be localized predominantly on small nociceptive sensory nerves. Since then, there has been an increasing number of papers exploring the role of P2X3 homomultimer and P2X2/3 heteromultimer receptors on sensory nerves in a wide range of organs, including skin, tongue, tooth pulp, intestine, bladder, and ureter that mediate the initiation of pain. Purinergic mechanosensory transduction has been proposed for visceral pain, where ATP released from epithelial cells lining the bladder, ureter, and intestine during distension acts on P2X3 and P2X2/3, and possibly P2Y, receptors on subepithelial sensory nerve fibers to send messages to the pain centers in the brain as well as initiating local reflexes. P1, P2X, and P2Y receptors also appear to be involved in nociceptive neural pathways in the spinal cord. P2X4 receptors on spinal microglia have been implicated in allodynia. The involvement of purinergic signaling in long-term neuropathic pain and inflammation as well as acute pain is discussed as well as the development of P2 receptor antagonists as novel analgesics. D
    [Show full text]
  • Potential Cannabis Antagonists for Marijuana Intoxication
    Central Journal of Pharmacology & Clinical Toxicology Bringing Excellence in Open Access Review Article *Corresponding author Matthew Kagan, M.D., Cedars-Sinai Medical Center, 8730 Alden Drive, Los Angeles, CA 90048, USA, Tel: 310- Potential Cannabis Antagonists 423-3465; Fax: 310.423.8397; Email: Matthew.Kagan@ cshs.org Submitted: 11 October 2018 for Marijuana Intoxication Accepted: 23 October 2018 William W. Ishak, Jonathan Dang, Steven Clevenger, Shaina Published: 25 October 2018 Ganjian, Samantha Cohen, and Matthew Kagan* ISSN: 2333-7079 Cedars-Sinai Medical Center, USA Copyright © 2018 Kagan et al. Abstract OPEN ACCESS Keywords Cannabis use is on the rise leading to the need to address the medical, psychosocial, • Cannabis and economic effects of cannabis intoxication. While effective agents have not yet been • Cannabinoids implemented for the treatment of acute marijuana intoxication, a number of compounds • Antagonist continue to hold promise for treatment of cannabinoid intoxication. Potential therapeutic • Marijuana agents are reviewed with advantages and side effects. Three agents appear to merit • Intoxication further inquiry; most notably Cannabidiol with some evidence of antipsychotic activity • THC and in addition Virodhamine and Tetrahydrocannabivarin with a similar mixed receptor profile. Given the results of this research, continued development of agents acting on cannabinoid receptors with and without peripheral selectivity may lead to an effective treatment for acute cannabinoid intoxication. Much work still remains to develop strategies that will interrupt and reverse the effects of acute marijuana intoxication. ABBREVIATIONS Therapeutic uses of cannabis include chronic pain, loss of appetite, spasticity, and chemotherapy-associated nausea and CBD: Cannabidiol; CBG: Cannabigerol; THCV: vomiting [8]. Recreational cannabis use is on the rise with more Tetrahydrocannabivarin; THC: Tetrahydrocannabinol states approving its use and it is viewed as no different from INTRODUCTION recreational use of alcohol or tobacco [9].
    [Show full text]
  • 102 the Effects of Intravesical
    102 Harper M, Brady C. M, Scaravilli F, Fowler C. J. Institute of Neurology, London THE EFFECTS OF INTRAVESICAL RESINIFERATOXIN ON SUBUROTHELIAL NERVE DENSITY IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY Aims of Study Somatic and autonomic neural pathways integrated in the CNS regulate urine storage and voiding. When spinal cord lesions disrupt these pathways, an aberrant segmental sacral reflex emerges, the afferent limb of which is comprised of small unmyelinated C-fibres that originate in the suburothelium. This pathological reflex is thought to be the underlying cause of “spinal” neurogenic detrusor overactivity (NDO). We are currently evaluating the role of resiniferatoxin (RTX) in the treatment of refractory “spinal” NDO. RTX is an ultra-potent capsaicin analogue purified from the dried latex of the succulent plant Euphorbia Resinifera. The vanillyl group of RTX facilitates the action of the vanilloid receptor (VR-1), a non-selective cation channel expressed on suburothelial C-fibres. Intravesical therapy with a single dose of RTX results in early acute excitatory effects (“sensitisation”) followed by inhibition of neuropeptide release and neuronal terminal field degeneration (“desensitisation”) (Avelino et al., 2001). In patients with refractory NDO, it has been shown that intravesical therapy with vanilloid compounds such as RTX or capsaicin significantly decreases lower urinary tract symptoms for a period of weeks or months, depending on factors such as dose and disease progression. It is thought that the eventual recurrence of symptoms is related to C-fibre regeneration. We have previously shown that the mean suburothelial nerve density decreases in patients who respond to capsaicin. Our experimental aim is to measure suburothelial nerve density in flexible cystoscopic biopsies in controls and patients with NDO before and after intravesical RTX or placebo.
    [Show full text]
  • TRP CHANNELS AS THERAPEUTIC TARGETS TRP CHANNELS AS THERAPEUTIC TARGETS from Basic Science to Clinical Use
    TRP CHANNELS AS THERAPEUTIC TARGETS TRP CHANNELS AS THERAPEUTIC TARGETS From Basic Science to Clinical Use Edited by ARPAD SZALLASI MD, PHD Department of Pathology, Monmouth Medical Center, Long Branch, NJ, USA AMSTERDAM • BOSTON • HEIDELBERG • LONDON NEW YORK • OXFORD • PARIS • SAN DIEGO SAN FRANCISCO • SINGAPORE • SYDNEY • TOKYO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 125 London Wall, London, EC2Y 5AS, UK 525 B Street, Suite 1800, San Diego, CA 92101-4495, USA 225 Wyman Street, Waltham, MA 02451, USA The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, UK First published 2015 Copyright © 2015 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our arrangement with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may be noted herein). Notices Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes in research methods, professional practices, or medical treatment may become necessary. Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds, or experiments described herein.
    [Show full text]
  • Cannabis Sativa: the Plant of the Thousand and One Molecules
    REVIEW published: 04 February 2016 doi: 10.3389/fpls.2016.00019 Cannabis sativa: The Plant of the Thousand and One Molecules Christelle M. Andre*, Jean-Francois Hausman and Gea Guerriero Environmental Research and Innovation, Luxembourg Institute of Science and Technology, Esch-sur-Alzette, Luxembourg Cannabis sativa L. is an important herbaceous species originating from Central Asia, which has been used in folk medicine and as a source of textile fiber since the dawn of times. This fast-growing plant has recently seen a resurgence of interest because of its multi-purpose applications: it is indeed a treasure trove of phytochemicals and a rich source of both cellulosic and woody fibers. Equally highly interested in this plant are the pharmaceutical and construction sectors, since its metabolites show potent bioactivities on human health and its outer and inner stem tissues can be used to make bioplastics and concrete-like material, respectively. In this review, the rich spectrum of hemp phytochemicals is discussed by putting a special emphasis on molecules of industrial interest, including cannabinoids, terpenes and phenolic Edited by: compounds, and their biosynthetic routes. Cannabinoids represent the most studied Eugenio Benvenuto, group of compounds, mainly due to their wide range of pharmaceutical effects in ENEA, Italian National Agency for New humans, including psychotropic activities. The therapeutic and commercial interests of Technologies, Energy and Sustainable Economic Development, Italy some terpenes and phenolic compounds, and in particular stilbenoids and lignans, are Reviewed by: also highlighted in view of the most recent literature data. Biotechnological avenues to Biswapriya Biswavas Misra, enhance the production and bioactivity of hemp secondary metabolites are proposed University of Florida, USA Felix Stehle, by discussing the power of plant genetic engineering and tissue culture.
    [Show full text]
  • The Handbook of Cannabis Therapeutics: from Bench to Bedside
    Handbook of Cannabis Therapeutics From Bench to Bedside 9780789030979 Handbook of Cannabis Therapeutics From Bench to Bedside Size: 212 x 152mm Spine size: 26 mm Color pages: Binding: Paperback THE HAWORTH PRESS® Haworth Series in Integrative Healing Ethan Russo Editor The Last Sorcerer: Echoes of the Rainforest by Ethan Russo Professionalism and Ethics in Complementary and Alternative Medicine by John Crellin and Fernando Ania Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential by Franjo Grotenhermen and Ethan Russo Modern Psychology and Ancient Wisdom: Psychological Healing Practices from the World’s Religious Traditions edited by Sharon G. Mijares Complementary and Alternative Medicine: Clinic Design by Robert A. Roush Herbal Voices: American Herbalism Through the Words of American Herbalists by Anne K. Dougherty The Healing Power of Chinese Herbs and Medicinal Recipes by Joseph P. Hou and Youyu Jin Alternative Therapies in the Treatment of Brain Injury and Neurobehavioral Disorders: A Practical Guide edited by Gregory J. Murrey Handbook of Cannabis Therapeutics: From Bench to Bedside edited by Ethan B. Russo and Franjo Grotenhermen Handbook of Cannabis Therapeutics From Bench to Bedside Ethan B. Russo, MD Franjo Grotenhermen, MD Editors Routledge Taylor &. Francis Croup NEW YORK AND LONDON First Published by The Haworth Press, Inc., 10 Alice Street, Binghamton, NY 13904-1580. Transferred to Digital Printing 2010 by Routledge 270 Madison Ave, New York NY 10016 2 Park Square, Milton Park, Abingdon, Oxon, OX14 4RN For more information on this book or to order, visit http://www.haworthpress.com/store/product.asp?sku=5741 or call 1-800-HAWORTH (800-429-6784) in the United States and Canada or (607) 722-5857 outside the United States and Canada or contact [email protected] © 2006 by The Haworth Press, Inc.
    [Show full text]